(AMCR) Amcor - Overview
Exchange: NYSE •
Country: Switzerland •
Currency: USD •
Type: Common Stock •
ISIN: JE00BJ1F3079
Stock: Flexible Packaging, Rigid Containers, Closures, Devices
Total Rating 21
Risk 60
Buy Signal -1.42
| Risk 5d forecast | |
|---|---|
| Volatility | 23.6% |
| Relative Tail Risk | -6.34% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.46 |
| Alpha | -23.25 |
| Character TTM | |
|---|---|
| Beta | 0.446 |
| Beta Downside | 0.132 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.38% |
| CAGR/Max DD | -0.17 |
EPS (Earnings per Share)
Revenue
Description: AMCR Amcor March 05, 2026
Amcor PLC (AMCR) is a Swiss-based company that produces and sells packaging products globally. The company operates in two primary segments: Global Flexible Packaging Solutions and Global Rigid Packaging Solutions.
The Global Flexible Packaging Solutions segment provides flexible packaging using materials like polymer resin, aluminum, and fiber. This segment serves diverse industries, including food and beverage, medical, pharmaceutical, and personal care. Flexible packaging is a significant part of the packaging sector due to its versatility and efficiency in material use.
The Global Rigid Packaging Solutions segment manufactures rigid containers, closures, and dispensing devices, primarily for food and beverage applications. Rigid packaging is essential for product protection and shelf life in many consumer goods categories.
Amcor distributes its products through a direct sales force. For more in-depth analysis, consider exploring ValueRays detailed reports.
Headlines to watch out for
- Global food and beverage demand drives flexible packaging sales
- Raw material price volatility impacts profit margins
- Sustainable packaging innovation attracts new customers
- Currency fluctuations affect international revenue translation
- Regulatory pressure increases plastic recycling costs
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income: 596.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.04 > 0.02 and ΔFCF/TA -0.36 > 1.0 |
| NWC/Revenue: 10.10% < 20% (prev 7.44%; Δ 2.65% < -1%) |
| CFO/TA 0.04 > 3% & CFO 1.60b > Net Income 596.0m |
| Net Debt (15.84b) to EBITDA (2.57b): 6.17 < 3 |
| Current Ratio: 1.30 > 1.5 & < 3 |
| Outstanding Shares: last quarter (463.8m) vs 12m ago 60.48% < -2% |
| Gross Margin: 18.20% > 18% (prev 0.20%; Δ 1.80k% > 0.5%) |
| Asset Turnover: 73.70% > 50% (prev 83.76%; Δ -10.06% > 0%) |
| Interest Coverage Ratio: 2.21 > 6 (EBITDA TTM 2.57b / Interest Expense TTM 559.0m) |
Altman Z'' 0.67
| A: 0.05 (Total Current Assets 8.56b - Total Current Liabilities 6.58b) / Total Assets 37.05b |
| B: 0.01 (Retained Earnings 393.0m / Total Assets 37.05b) |
| C: 0.05 (EBIT TTM 1.24b / Avg Total Assets 26.61b) |
| D: -0.02 (Book Value of Equity -579.0m / Total Liabilities 25.40b) |
| Altman-Z'' Score: 0.67 = B |
Beneish M -2.32
| DSRI: 1.23 (Receivables 3.16b/1.77b, Revenue 19.61b/13.54b) |
| GMI: 1.11 (GM 18.20% / 20.17%) |
| AQI: 1.21 (AQ_t 0.53 / AQ_t-1 0.44) |
| SGI: 1.45 (Revenue 19.61b / 13.54b) |
| TATA: -0.03 (NI 596.0m - CFO 1.60b) / TA 37.05b) |
| Beneish M-Score: -2.32 (Cap -4..+1) = BBB |
What is the price of AMCR shares?
As of March 19, 2026, the stock is trading at USD 40.71 with a total of 3,590,456 shares traded.
Over the past week, the price has changed by -3.30%, over one month by -16.78%, over three months by -1.45% and over the past year by -12.34%.
Over the past week, the price has changed by -3.30%, over one month by -16.78%, over three months by -1.45% and over the past year by -12.34%.
Is AMCR a buy, sell or hold?
Amcor has received a consensus analysts rating of 3.90.
Therefore, it is recommended to buy AMCR.
- StrongBuy: 3
- Buy: 3
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the AMCR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 53.5 | 31.4% |
| Analysts Target Price | 53.5 | 31.4% |
AMCR Fundamental Data Overview March 18, 2026
P/E Trailing = 30.5263
P/E Forward = 10.0604
P/S = 0.9567
P/B = 1.6122
P/EG = 0.5029
Revenue TTM = 19.61b USD
EBIT TTM = 1.24b USD
EBITDA TTM = 2.57b USD
Long Term Debt = 14.62b USD (from longTermDebt, last quarter)
Short Term Debt = 519.0m USD (from shortTermDebt, last quarter)
Debt = 16.90b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 15.84b USD (from netDebt column, last quarter)
Enterprise Value = 34.60b USD (18.76b + Debt 16.90b - CCE 1.06b)
Interest Coverage Ratio = 2.21 (Ebit TTM 1.24b / Interest Expense TTM 559.0m)
EV/FCF = 21.31x (Enterprise Value 34.60b / FCF TTM 1.62b)
FCF Yield = 4.69% (FCF TTM 1.62b / Enterprise Value 34.60b)
FCF Margin = 8.28% (FCF TTM 1.62b / Revenue TTM 19.61b)
Net Margin = 3.04% (Net Income TTM 596.0m / Revenue TTM 19.61b)
Gross Margin = 18.20% ((Revenue TTM 19.61b - Cost of Revenue TTM 16.04b) / Revenue TTM)
Gross Margin QoQ = 16.43% (prev 19.56%)
Tobins Q-Ratio = 0.93 (Enterprise Value 34.60b / Total Assets 37.05b)
Interest Expense / Debt = 0.91% (Interest Expense 154.0m / Debt 16.90b)
Taxrate = 1.67% (3.00m / 180.0m)
NOPAT = 1.22b (EBIT 1.24b * (1 - 1.67%))
Current Ratio = 1.30 (Total Current Assets 8.56b / Total Current Liabilities 6.58b)
Debt / Equity = 1.45 (Debt 16.90b / totalStockholderEquity, last quarter 11.64b)
Debt / EBITDA = 6.17 (Net Debt 15.84b / EBITDA 2.57b)
Debt / FCF = 9.76 (Net Debt 15.84b / FCF TTM 1.62b)
Total Stockholder Equity = 9.73b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.24% (Net Income 596.0m / Total Assets 37.05b)
RoE = 6.12% (Net Income TTM 596.0m / Total Stockholder Equity 9.73b)
RoCE = 5.08% (EBIT 1.24b / Capital Employed (Equity 9.73b + L.T.Debt 14.62b))
RoIC = 5.31% (NOPAT 1.22b / Invested Capital 22.95b)
WACC = 4.40% (E(18.76b)/V(35.66b) * Re(7.56%) + D(16.90b)/V(35.66b) * Rd(0.91%) * (1-Tc(0.02)))
Discount Rate = 7.56% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 26.90%
[DCF] Terminal Value 87.13% ; FCFF base≈1.28b ; Y1≈1.39b ; Y5≈1.74b
[DCF] Fair Price = 77.21 (EV 51.52b - Net Debt 15.84b = Equity 35.68b / Shares 462.0m; r=5.90% [WACC]; 5y FCF grow 9.92% → 2.90% )
EPS Correlation: -32.11 | EPS CAGR: -3.94% | SUE: 0.34 | # QB: 0
Revenue Correlation: 46.39 | Revenue CAGR: 10.81% | SUE: -1.42 | # QB: 0
EPS current Year (2026-06-30): EPS=3.98 | Chg7d=+0.000 | Chg30d=-0.020 | Revisions Net=-4 | Growth EPS=+11.9% | Growth Revenue=+52.9%
EPS next Year (2027-06-30): EPS=4.42 | Chg7d=+0.000 | Chg30d=-0.013 | Revisions Net=-2 | Growth EPS=+11.0% | Growth Revenue=+1.7%
[Analyst] Revisions Ratio: -0.50 (2 Up / 6 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 4.7% (Discount Rate 7.9% - Earnings Yield 3.3%)
[Growth] Growth Spread = -3.0% (Analyst 1.7% - Implied 4.7%)
P/E Forward = 10.0604
P/S = 0.9567
P/B = 1.6122
P/EG = 0.5029
Revenue TTM = 19.61b USD
EBIT TTM = 1.24b USD
EBITDA TTM = 2.57b USD
Long Term Debt = 14.62b USD (from longTermDebt, last quarter)
Short Term Debt = 519.0m USD (from shortTermDebt, last quarter)
Debt = 16.90b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 15.84b USD (from netDebt column, last quarter)
Enterprise Value = 34.60b USD (18.76b + Debt 16.90b - CCE 1.06b)
Interest Coverage Ratio = 2.21 (Ebit TTM 1.24b / Interest Expense TTM 559.0m)
EV/FCF = 21.31x (Enterprise Value 34.60b / FCF TTM 1.62b)
FCF Yield = 4.69% (FCF TTM 1.62b / Enterprise Value 34.60b)
FCF Margin = 8.28% (FCF TTM 1.62b / Revenue TTM 19.61b)
Net Margin = 3.04% (Net Income TTM 596.0m / Revenue TTM 19.61b)
Gross Margin = 18.20% ((Revenue TTM 19.61b - Cost of Revenue TTM 16.04b) / Revenue TTM)
Gross Margin QoQ = 16.43% (prev 19.56%)
Tobins Q-Ratio = 0.93 (Enterprise Value 34.60b / Total Assets 37.05b)
Interest Expense / Debt = 0.91% (Interest Expense 154.0m / Debt 16.90b)
Taxrate = 1.67% (3.00m / 180.0m)
NOPAT = 1.22b (EBIT 1.24b * (1 - 1.67%))
Current Ratio = 1.30 (Total Current Assets 8.56b / Total Current Liabilities 6.58b)
Debt / Equity = 1.45 (Debt 16.90b / totalStockholderEquity, last quarter 11.64b)
Debt / EBITDA = 6.17 (Net Debt 15.84b / EBITDA 2.57b)
Debt / FCF = 9.76 (Net Debt 15.84b / FCF TTM 1.62b)
Total Stockholder Equity = 9.73b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.24% (Net Income 596.0m / Total Assets 37.05b)
RoE = 6.12% (Net Income TTM 596.0m / Total Stockholder Equity 9.73b)
RoCE = 5.08% (EBIT 1.24b / Capital Employed (Equity 9.73b + L.T.Debt 14.62b))
RoIC = 5.31% (NOPAT 1.22b / Invested Capital 22.95b)
WACC = 4.40% (E(18.76b)/V(35.66b) * Re(7.56%) + D(16.90b)/V(35.66b) * Rd(0.91%) * (1-Tc(0.02)))
Discount Rate = 7.56% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 26.90%
[DCF] Terminal Value 87.13% ; FCFF base≈1.28b ; Y1≈1.39b ; Y5≈1.74b
[DCF] Fair Price = 77.21 (EV 51.52b - Net Debt 15.84b = Equity 35.68b / Shares 462.0m; r=5.90% [WACC]; 5y FCF grow 9.92% → 2.90% )
EPS Correlation: -32.11 | EPS CAGR: -3.94% | SUE: 0.34 | # QB: 0
Revenue Correlation: 46.39 | Revenue CAGR: 10.81% | SUE: -1.42 | # QB: 0
EPS current Year (2026-06-30): EPS=3.98 | Chg7d=+0.000 | Chg30d=-0.020 | Revisions Net=-4 | Growth EPS=+11.9% | Growth Revenue=+52.9%
EPS next Year (2027-06-30): EPS=4.42 | Chg7d=+0.000 | Chg30d=-0.013 | Revisions Net=-2 | Growth EPS=+11.0% | Growth Revenue=+1.7%
[Analyst] Revisions Ratio: -0.50 (2 Up / 6 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 4.7% (Discount Rate 7.9% - Earnings Yield 3.3%)
[Growth] Growth Spread = -3.0% (Analyst 1.7% - Implied 4.7%)